
GitLab (GTLB) Stock Forecast & Price Target
GitLab (GTLB) Analyst Ratings
Bulls say
GitLab is supported by a differentiated single-application DevSecOps platform that spans the full software lifecycle, giving it a stronger enterprise value proposition than stitched-together point solutions and helping it compete with Microsoft’s GitHub. Its AI strategy is gaining early traction, with Duo Agent Platform attaching to 4 of the top 10 deals, paid CRR above $20M, and new logo growth up 30% y/y in F1Q27, while management also emphasized improving win rates and a global first-order team ramp. The long runway in a market Gartner sees reaching $6.4B by 2028, plus product innovation such as GitLab Orbit, Governance for Agents, and flexible monetization through GitLab Credits and Flex, supports a positive view on growth durability and margin expansion.
Bears say
GitLab is facing a weakening fundamental setup as DBNRR has fallen for nine consecutive quarters, new logo acquisition remains difficult in a saturated DevSecOps market, and tech layoffs are pressuring seat growth, while the newest business cohort continues to shrink. The company’s F2Q27 revenue growth guide of about 15% to 16% implies a sharp deceleration from 23% in F1Q27, and management is also assuming limited recovery in a PubSec segment that is only about 13% of the business plus no material DAP contribution in FY27. Competitive pressure is intensifying from Microsoft’s GitHub and Atlassian, while Act 2 restructuring, which cuts about 14% of the workforce and carries $30-35M of pre-tax charges, is largely being reinvested rather than driving near-term margin expansion.
This aggregate rating is based on analysts' research of GitLab and is not a guaranteed prediction by Public.com or investment advice.
GitLab (GTLB) Analyst Forecast & Price Prediction
Start investing in GitLab (GTLB)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About GitLab (GTLB) Forecast
GitLab (GTLB) Analyst Forecast & Price Prediction
Start investing in GitLab (GTLB)
Order type
Buy in
Order amount
Est. shares
0 shares